| Net Cash Provided by (Used in) Operating Activities |
$4,982 |
USD |
|
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$2,079 |
USD |
|
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$579 |
USD |
|
Q2 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
75,000,000 |
shares |
|
Q3 2025 |
Q2 2026 |
| Common Stock, Shares, Issued |
22,400,000 |
shares |
|
Q3 2025 |
Q2 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2025 |
Q2 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$6,482 |
USD |
|
Q2 2025 |
Q1 2026 |
| Depreciation |
$503 |
USD |
|
Q2 2025 |
Q1 2026 |
| Payments to Acquire Property, Plant, and Equipment |
$579 |
USD |
|
Q2 2025 |
Q1 2026 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$3,804 |
USD |
|
Q3 2025 |
Q2 2026 |
| Property, Plant and Equipment, Gross |
$6,034 |
USD |
|
Q3 2025 |
Q2 2026 |
| Additional Paid in Capital |
$35,760 |
USD |
|
Q3 2025 |
Q2 2026 |
| Depreciation, Depletion and Amortization |
$503 |
USD |
|
Q2 2025 |
Q1 2026 |